(S)-3-(p-Tolyl)morpholine hydrochloride, 97.0%, 1g

ETHYL 4-OXOBUTANOATE, 95.0%, 250mg

Methyl 4-hydroxy-5-methoxy-1-methyl-2-oxo-1,2-dihydroquinoline-3-carboxylate, 97%, 100mg

h-Threoninol, 95.0%, 10g

(S)-9-Fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-3,7-dihydro-2H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid hydrochloride, 97.0%, 25g

(bromodiphenylmethyl)benzene, 95.0%, 100g

Pd-Dihydrogentetrachloropalladate(II), solution 5 g

(R)-(-)-DBD-APy [=(R)-(-)-4-(N,N-Dimethylaminosulfonyl)-7-(3-aminopyrrolidin-1-yl)-2,1,3-benzoxadiazole] [HPLC Labeling Reagent for e.e. Determination]>98.0%(HPLC)100mg

Solution tampon pH 9,22 ±0,02 (20 °C), ROTI®Calipure, prête à l'emploi, 500 ml

tert-butyl 4-amino-4-(trifluoromethyl)piperidine-1-carboxylate, 95.0%, 10g

(4-Bromophenyl)(4-hydroxyphenyl)methanone, 97%, 1g

N-Allylaniline>99.0%(GC)100mL

(4-Chloropyridin-3-yl)boronic acid hydrochloride, 95.0%, 1g